Pharmacokinetic and Toxicokinetic (PK/TK) studies are critical in evaluating the safety and efficacy of a drug from discovery through post-marketing clinical trials.
As a complement to our bioanalytical services, Alturas Analytics incorporates PK/TK reporting, using validated WinNonlin®, under a single Quality Assurance Unit. This ensures a seamless and comprehensive GLP compliant analytical package of the highest integrity and reduces the overall time to report finalization. Our team of scientific experts will help translate complex data into actionable insights, enabling Sponsors to make informed strategic decisions across the entire drug development spectrum.
Single/Multi-dose Study Design
Co-administered Drug Parent/Metabolite
Submission Ready Reports
Speak with an Expert
Sara is the Lead PK Analyst and Technical Writer at Alturas Analytics, Inc. Sara has over 20 years of experience in the biotechnology and pharmaceutical industry after graduating with a B.S. in Genetics and Cell Biology.